Willner & Heller’s Moderna MRNA Stock Holding History

Willner & Heller’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,235	Closed	-$262K	–	154
2025 Q1	$262K	Buy	9,235 +2,215	+32%	+$78.6K	0.24%	125
2024 Q4	$292K	Sell	7,020 -275	-4%	-$13.1K	0.26%	118
2024 Q3	$488K	Buy	+7,295	New	+$670K	0.43%	78

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Willner & Heller's MRNA Position: Q2 2025 in Review

Willner & Heller sold out of Moderna (MRNA) in Q2 2025, closing a stake of 9,235 shares — an estimated $262K sold.

Willner & Heller first reported a position in MRNA in Q3 2024 and held it in 3 quarters. The position peaked at $488K in Q3 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

Willner & Heller reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
Willner & Heller sold 9,235 Moderna shares in Q2 2025, an estimated $262K.
Willner & Heller first reported a position in Moderna in Q3 2024 and held it in 3 quarters.
Willner & Heller's Moderna position peaked at $488K in Q3 2024.
674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Willner & Heller's 13F filing for Q2 2025, filed 22 Jul 2025.